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Medicine
Marco Carrozzo1,2
1 Professor of Oral Medicine, Dental School, Newcastle University, United Kingdom
2 President of the European Association of Oral Medicine, United KingdomOral Medicine (OM) is generally defined as the branch of
dentistry related to the oral health care of patients suffering
from chronic recurrent and medically related disorders of the
mouth and maxillofacial region with their diagnosis and mostly
non-surgical management. OM was originally called dental
medicine and it is sometimes termed oral and maxillofacial
medicine and, mainly in the Ibero-American world and in
Southern Europe, also stomatology [1].
Scopes and definition of OM are not the same everywhere
and these differences are likely the result of cultural, economic,
differences, heterogeneity of settings and health care systems.
However, there is a broad agreement about clinical activities as
OM practice in mainly devoted to the diagnosis and
management of oral mucosal lesions, salivary gland disorders,
and oral manifestations of dermatologic, gastrointestinal,
infectious diseases (such as but not restricted to HIV and HCV),
and facial pain [2].
OM works closely with other Dental (mainly Oral Pathology,
Oral Radiology, Periodontology, Geriatric Dentistry, Oral Surgery,
Special Need Dentistry) and Medical (especially Oral andMaxillo-
Facial Surgery, Dermatology, Otorhinolaryngology, Gastroenter-
ology, Ophthalmology, Rheumatology, Neurology) specialties.
OM has an active research component: just as an example
and without any wish to be comprehensive, land marking
discoveries published by OM colleagues include fields as
Infectious diseases [3,4], Hepatology [5], Oncology [6],
Rheumatology [7], and Pharmacology [8].
OM is recognized as a specialty by Local Registering
Authorities in Europe in Croatia, Israel and United Kingdom
whereas OM training is a distinct field of study in Finland,
Greece, Ireland, Italy, Spain, Sweden [2].
The European Association of Oral Medicine (EAOM) was
founded 1998 in London by Professors Crispian Scully (United
Kingdom) and Isaac van der Waal (Netherlands) along with
Professors Sir David Mason, Tony Axéll (Scandinavia), Antonio
Azul (Portugal), and Stephen Challacombe (United Kingdom)
[1] and I am honoured to be the 10th President of the Society.This is an Open Access article distributed under the terms of the Creative Commons A
unrestricted use, distribution, and reproduction in any medium, provided the originEAOM aims to improve clinical care in the field of OM and to
promote education and research in OM and also to inform
governments and other official institutions of the significance
of OM for oral and systemic health. The latter is particularly
relevant for a broader official recognition of OM in Europe and
worldwide.
EAOM activities are not just limited to Europe and the
Society has a truly international vocation and is willing to
engage with any dentist and/or medical doctor who share an
interest in OM regardless of the geographic and training
background.
EAOM has, for example, a consistent number of fellows from
USA, Japan, Brazil and Thailand.
We run increasingly successful biannual meetings. The next
one will be held in September 2018 in Gothenburg, Sweden,
jointly with the World Workshop of Oral Medicine and we will
celebrate the 20th Anniversary of EAOM.
EAOM is also strongly committed to support young
colleagues who are starting their career in OM through
monetary competitive prizes and travel bursaries.
Kindly keep in touch through EAOM web-site (http://www.
eaom.eu/) and/or feel free to contact myself or the EAOM
secretary if you are thinking to join our big OM community or
simply to gain more information about our activities and to
discover the advantage to be an EAOM member.References
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